Citations

Mayo Clinic

Showing 10 of 108599 citations.

Lingering Questions Concerning Intensive Care Unit Utilization
Hyder, Joseph A.

JAMA Internal Medicine | February 6, 2017 | Volume: 177 | Issue: 2 | Pages: 289

10.1001/jamainternmed.2016.8750 | PMID 28166348 Get It

Antibody Prevalence in Epilepsy (APE) Score—Evolution in Autoimmune Epilepsy Practice
McKeon, Andrew , McKeon, Andrew

JAMA Neurology | February 6, 2017 | Volume: 74 | Issue: 4 | Pages: 384

10.1001/jamaneurol.2016.5479 | PMID 28166361 Get It

Molecular Biomarkers for the Evaluation of Colorectal Cancer
Sepulveda, Antonia R. , Allegra, Carmen J. , Grody, Wayne W., Cushman‐Vokoun, Allison M. , Funkhouser, William K., Kopetz, Scott , Lindor, Noralane M. , Minsky, Bruce D. , Monzon, Federico A. , Singh, Veena , Clark, Jennifer , Colasacco, Carol , Temple‐Smolkin, Robyn , Ventura, Christina B., Nowak, Jan A. , Hamilton, Stanley R. , Lieu, Christopher H. , Sargent, Daniel J. , Willis, Joseph , Rumble, R. Bryan , Kopetz, Scott

American Journal of Clinical Pathology | February 6, 2017 | Volume: 147 | Issue: 3 | Pages: 221-260

10.1093/ajcp/aqw209 | PMID 28165529 Get It

Abstract Objectives: To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing of colorectal cancer (CRC) tissues to guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. Methods: The American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology convened an expert panel to develop an evidence-based guideline to establish standard molecular biomarker testing and guide therapies for patients with CRC. A comprehensive literature search that included more than 4,000 articles was conducted. Results: Twenty-one guideline statements were established. Conclusions: Evidence supports mutational testing for EGFR signaling pathway genes, since they provide clinically actionable information as negative predictors of benefit to anti-EGFR monoclonal antibody therapies for targeted therapy of CRC. Mutations in several of the biomarkers have clear prognostic value. Laboratory approaches to operationalize CRC molecular testing are presented.
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology
Sepulveda, Antonia R. , Allegra, Carmen J. , Grody, Wayne W., Cushman‐Vokoun, Allison M. , Funkhouser, William K., Kopetz, Scott , Lindor, Noralane M. , Minsky, Bruce D. , Monzon, Federico A. , Singh, Veena , Clark, Jennifer , Temple‐Smolkin, Robyn , Ventura, Christina B., Nowak, Jan A. , Hamilton, Stanley R. , Lieu, Christopher H. , Sargent, Daniel J. , Willis, Joseph , Colasacco, Carol , Rumble, R. Bryan , Kopetz, Scott

Archives of Pathology & Laboratory Medicine | February 6, 2017 | Volume: 141 | Issue: 5 | Pages: 625-657

10.5858/arpa.2016-0554-cp | PMID 28165284 Get It

Objectives.— To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing of colorectal cancer (CRC) tissues to guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. Methods.— The American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology convened an expert panel to develop an evidence-based guideline to establish standard molecular biomarker testing and guide therapies for patients with CRC. A comprehensive literature search that included more than 4,000 articles was conducted. Results.— Twenty-one guideline statements were established. Conclusions.— Evidence supports mutational testing for EGFR signaling pathway genes, since they provide clinically actionable information as negative predictors of benefit to anti-EGFR monoclonal antibody therapies for targeted therapy of CRC. Mutations in several of the biomarkers have clear prognostic value. Laboratory approaches to operationalize CRC molecular testing are presented.
Changes in management of stress urinary incontinence following the 2011 FDA Health Notification
Khan, Aqsa , Rosenblum, Nirit , Brucker, Benjamin M. , Νitti, Victor W.

Journal of Clinical Urology | February 6, 2017 | Volume: 10 | Issue: 5 | Pages: 440-448

10.1177/2051415817691662 Get It

Purpose: We sought to assess for impact on management trends in new patients presenting to our institution with stress urinary incontinence (SUI) following the release of the FDA Health Notification in July 2011 for vaginal mesh. Materials and methods: Chart analysis was performed on patients assigned a primary International Classification of Diseases (ICD-9) diagnosis code of 625.6 for SUI at initial consultation by two providers at our institution between June 1, 2010 and November 30, 2014. Rates of treatment and types of procedures performed were analyzed: urethral bulking, mesh sling, or pubovaginal sling. Results: A total of 333 new patients were identified with an increasing trend over time. One hundred and twenty-three patients underwent 153 procedures for stress incontinence. The mean proportion that had a procedure per six-month period was 37%, with decreasing proportions over time. Initially all procedures were midurethral mesh slings, with a decline at the time of and after the notification, and a temporary increase in bulking procedures. Subsequently, there was a rise again in sling placement, namely with an increase in pubovaginal slings. Of the 20 pubovaginal slings placed, 13 were placed in patients who had a prior anti-incontinence surgery (eight for sling failure, vaginal mesh, or fixed urethra, and two in patients with mesh extrusion/erosion). Seven were performed in patients who had never had prior surgery (two for very high-grade incontinence, two with urethral diverticulectomy, and three in patients who expressed concern about mesh). Conclusions: Although there were an increasing number of patients seen for management of SUI over time, there was a progressive decrease in the proportion of patients having anti-incontinence procedures after release of the FDA notification. There was an overall decrease in the use of mesh slings and an increase in bulking, and more notably, placement of pubovaginal slings.
Discrepancies in Communication Versus Documentation of Weight-Management Benchmarks
Turer, Christy B. , Barlow, Sarah E. , Montaño, Sergio, Flores, Glenn, Flores, Glenn

Global Pediatric Health | February 6, 2017 | Volume: 4 | Issue: No issue available | Pages: No page available

10.1177/2333794x16685190 | PMID 28239625 Get It

To examine gaps in communication versus documentation of weight-management clinical practices, communication was recorded during primary care visits with 6- to 12-year-old overweight/obese Latino children. Communication/documentation content was coded by 3 reviewers using communication transcripts and health-record documentation. Discrepancies in communication/documentation content codes were resolved through consensus. Bivariate/multivariable analyses examined factors associated with discrepancies in benchmark communication/documentation. Benchmarks were neither communicated nor documented in up to 42% of visits, and communicated but not documented or documented but not communicated in up to 20% of visits. Lowest benchmark performance rates were for laboratory studies (35%) and nutrition/weight-management referrals (42%). In multivariable analysis, overweight (vs obesity) was associated with 1.6 more discrepancies in communication versus documentation ( P = .03). Many weight-management benchmarks are not met, not documented, or performed without being communicated. Enhanced communication with families and documentation in health records may promote lifestyle changes in overweight children and higher quality care for overweight children in primary care.
The THOR group and the way (far) forward: transfusion medicine support is vital to the mission!
Stubbs, James R.

Transfusion | February 6, 2017 | Volume: 57 | Issue: 3 | Pages: 714-715

10.1111/trf.14011 | PMID 28164309 Get It

Pulmonary Complications of Aneurysmal Subarachnoid Hemorrhage
Friedman, Jonathan A., Pichelmann, Mark A., Piepgras, David G., McIver, Jon I., McClelland, Robyn L. , Nichols, Douglas A., Meyer, Fredric B. , Atkinson, John L. D., Toussaint, L. Gerard , Wijdicks, Eelco F. M.

Neurosurgery | February 5, 2017 | Volume: 52 | Issue: 5 | Pages: 1025-1032

10.1093/neurosurgery/52.5.1025 Get It

Abstract OBJECTIVE Pulmonary complications challenge the medical management of patients who have sustained aneurysmal subarachnoid hemorrhage (SAH). We assessed the frequency and types of pulmonary complications after aneurysmal SAH and analyzed the impact of pulmonary complications on patient outcome. METHODS We reviewed the records of all patients with acute SAH treated at our institution between 1990 and 1997. Three hundred five consecutive patients with an aneurysmal hemorrhage source documented by angiography and treated within 7 days of ictus were analyzed. Outcomes at longest follow-up (mean, 16 mo) were measured by use of the Glasgow Outcome Scale. RESULTS Pulmonary complications were documented in 66 patients (22%). The pulmonary complications were nosocomial pneumonia in 26 patients (9%), congestive heart failure in 23 (8%), aspiration pneumonia in 17 (6%), neurogenic pulmonary edema in 5 (2%), pulmonary embolus in 2 (<1%), and other pulmonary disorders in 4 (1%); 11 patients had two pulmonary complications. The incidence of symptomatic vasospasm was greater in patients with pulmonary complications (63%) than in patients without pulmonary complications (31%) (P= 0.001), and this association was independent of age and clinical grade at admission (odds ratio, 3.68; P< 0.001). Overall clinical outcomes were worse in patients with pulmonary complications (mean Glasgow Outcome Scale score, 3.3) than in patients without pulmonary complications (mean Glasgow Outcome Scale score, 4.0; P= 0.0001), but pulmonary complications were not an independent predictor of worse outcome when adjusted for age and clinical grade at admission (odds ratio, 1.38; P= 0.315). CONCLUSION Patients who experience pulmonary complications after aneurysmal SAH have a higher incidence of symptomatic vasospasm than do patients without pulmonary complications. This most likely reflects both the failure to maintain aggressive hypervolemic and hyperdynamic therapy in patients with pulmonary compromise and the possible precipitation of congestive heart failure by hypervolemic therapy in patients with preexisting delayed ischemic neurological deficit. Although patients with pulmonary complications have worse overall clinical outcomes than do patients without pulmonary complications, this is attributable to older age and worse clinical grades at admission.
Simulated Lumbar Minimally Invasive Surgery Educational Model With Didactic and Technical Components
Ghobrial, George M. , Lobel, Darlene A., Chitale, Rohan V , Harrop, James Shields

Neurosurgery | February 5, 2017 | Volume: 73 | Issue: suppl_1 | Pages: S107-S110

10.1093/neurosurgery/73.suppl_1.s107 Get It

Abstract BACKGROUND: The learning and development of technical skills are paramount for neurosurgical trainees. External influences and a need for maximizing efficiency and proficiency have encouraged advancements in simulator-based learning models. OBJECTIVE: To confirm the importance of establishing an educational curriculum for teaching minimally invasive techniques of pedicle screw placement using a computer-enhanced physical model of percutaneous pedicle screw placement with simultaneous didactic and technical components. METHODS: A 2-hour educational curriculum was created to educate neurosurgical residents on anatomy, pathophysiology, and technical aspects associated with image-guided pedicle screw placement. Predidactic and postdidactic practical and written scores were analyzed and compared. Scores were calculated for each participant on the basis of the optimal pedicle screw starting point and trajectory for both fluoroscopy and computed tomographic navigation. RESULTS: Eight trainees participated in this module. Average mean scores on the written didactic test improved from 78% to 100%. The technical component scores for fluoroscopic guidance improved from 58.8 to 52.9. Technical score for computed tomography—navigated guidance also improved from 28.3 to 26.6. CONCLUSION: Didactic and technical quantitative scores with a simulator-based educational curriculum improved objectively measured resident performance. A minimally invasive spine simulation model and curriculum may serve a valuable function in the education of neurosurgical residents and outcomes for patients.
Lumbar Lordosis and Pelvic Inclination in Adults With Chronic Low Back Pain
Youdas, James W., Garrett, Tom R., Egan, Kathleen S., Therneau, Terry M.

Physical Therapy | February 5, 2017 | Volume: 80 | Issue: 3 | Pages: 261-275

10.1093/ptj/80.3.261 Get It

AbstractBackground and Purpose. The causes of lumbopelvic imbalances in standing have been widely accepted by physical therapists, but there is a lack of scientific evidence available to support them. We examined the association between 9 variables and pelvic inclination and lumbar lordosis during relaxed standing. Subjects. Thirty men and 30 women with chronic low back pain (CLBP) for at least 4 months were examined (mean age=54.9 years, SD=9, range=40.4–69.8). Methods. Multiple linear regression modeling was used to assess the association of pelvic inclination and the magnitude of lumbar lordosis in standing with age, sex, body mass index (BMI), Oswestry Back Pain Disability Questionnaire (ODQ) scores, physical activity level, hip flexor muscle length, abdominal muscle force, and range of motion (ROM) for lumbar flexion and extension. Results. In women, age, BMI, and ODQ scores were associated univariately and multivariately with pelvic inclination. In men, lumbar extension ROM was related univariately to pelvic inclination; age, lumbar extension ROM, and ODQ scores were associated multivariately. Lumbar lordosis was associated univariately with only lumbar extension ROM for women and men. A weak correlation was found between angle of pelvic inclination and magnitude of lumbar lordosis in standing (r=.31 for women, r=.37 for men). Conclusion and Discussion. The odds ratio of having CLBP is increased if the score on the double-leg lowering test for abdominal muscles exceeds 50 degrees for men and 60 degrees for women. In patients with CLBP, the magnitude of the lumbar lordosis and pelvic inclination in standing is not associated with the force production of the abdominal muscles.